Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

TTP Labtech Launches acumen® hci for Rapid Multiplexed Imaging

Published: Tuesday, January 08, 2013
Last Updated: Monday, January 07, 2013
Bookmark and Share
High throughput meets high content imaging for cell-based primary screening.

TTP Labtech has announced the release of the acumen® hci (high content imaging) system, developed for researchers who are looking to increase the productivity of their high throughput imaging.

Replacing the acumen eX3, the new acumen hci is the fastest imager on the market for multiplex assays in up to 1536-wellplates, and the new open-source image format means users have complete flexibility to analyze images on their existing analysis software if required.

Together with whole-well imaging, these features make the acumen hci ideal for identifying “hit” wells in cell-based screens. The new system will be premiered at SLAS2013 (12-16 January 2013) on the TTP Labtech booth #1213.

Achieving unparalleled speeds during high throughput screening, acumen hci can image and analyze the whole wells of a 96- to 1536-well plates in just 8 minutes, at a resolution of 0.5µm/pixel.

This enables the effective screening of high density plates and facilitates assay miniaturization, with associated increase in throughput and reduced costs.

Data is robust and insightful even during rapid screening, and up to three lasers allow for easy multiplexing using a wide range of fluorescent dyes.

The new 561nm laser option offers compatibility with even more dyes, like mCherry. Furthermore, with intuitive operation, multiple members of staff can be easily trained on the acumen hci for efficient use of the screening program.

The acumen hci incorporates TTP Labtech’s proprietary cellista software which enables high throughput whole well imaging of a greater range of hard-to-automate assays, including angiogenesis, neurite outgrowth, nuclear localization, translocation and cytotoxicity.

The novel open-source, OME-compliant TIFF images can be exported without reducing scan times and are easily imported into a range of open source and commercial image analysis packages, so they can easily fit into existing workflows.

The acumen hci is also compatible with microscope slides using the wide field objective, for imaging of whole tissue sections in minutes.

Paul Wylie, product manager of acumen at TTP Labtech, commented, “The new acumen hci rises to the challenge of speed versus high content, without compromise on either side. We have developed it as the perfect complement to traditional imaging systems. The acumen hci can be used for cell based assays including compound screening and RNAi studies to provide images of “hit” wells at the highest throughput. These specific hits can then be further analyzed for hit confirmation at slower speeds and higher magnification if required.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

David Newble Joins TTP Labtech as New Managing Director
Recent appointment promises to drive innovation strategy and further strengthen R&D pipeline
Thursday, June 18, 2015
TTP Labtech Revenues up 43%
The company has reported an impressive 43% increase in revenues and an associated increase in profits over 2013.
Monday, June 23, 2014
TTP Labtech Announces On-Going Growth
An investment of £3.8M in global R&D sees product sales grow over 20%.
Thursday, July 11, 2013
Increased Demand Drives Queensland Compound Library Expansion
QCL capacity is increased by the acquisition of a fourth additional comPOUND® storage module.
Thursday, June 10, 2010
TTP LabTech Delivers Automated Chemistry System for Salt and Polymorph Screening to AstraZeneca
The three year laboratory automation project involved the design and build of a fully automated system for salt and polymorph screening of novel compounds.
Wednesday, January 28, 2009
TTP LabTech's European Roadshow
The roadshow offers the opportunity to try out the latest in low-volume liquid handling and high content screening systems, as well as learning more about compound management, instrumentation development and custom automation.
Thursday, September 13, 2007
TTP LabTech Announce US Expansion to Meet Growing Customer Demand
TTP LabTech further expands its US facilities with the recruitment of sales and customer service personnel for its East Coast office in Cambridge, MA.
Monday, July 30, 2007
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos